Epigenomic and proteomic analyses provide insights into early-life immune regulation and asthma development in

Yijun Li1, Zhaozhong Zhu2, Carlos A Camargo2

  • 1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Nature Communications
|April 14, 2025
PubMed

Insights

Severe bronchiolitis in infants increases childhood respiratory risks. DNA methylation in infant blood is linked to later wheezing and asthma, potentially through immune responses. This study identifies key epigenetic markers and proteins like ST2.

Area of Science:

  • Epigenetics
  • Immunology
  • Pediatric Respiratory Medicine

Background:

  • Infants hospitalized for severe bronchiolitis have a higher risk of developing childhood respiratory diseases.
  • Early-life respiratory infections can have long-term consequences on lung health.

Purpose of the Study:

  • To investigate the role of DNA methylation in infants with severe bronchiolitis.
  • To identify epigenetic markers associated with recurrent wheezing and asthma development by age 6.
  • To explore the relationship between DNA methylation, protein levels, and asthma risk.

Main Methods:

  • Epigenome-wide association studies (EWAS) were performed on infant blood samples.
  • Differentially methylated regions (DMRs) were identified and analyzed for associations with wheezing and asthma.
  • Correlation analyses were conducted between DMRs and circulating protein levels.
  • Mendelian randomization was used to assess the causal effect of ST2 protein on asthma.

Main Results:

  • 61 DMRs were associated with recurrent wheezing and/or asthma.
  • These DMRs were enriched in neutrophil enhancers and showed interactions with rhinovirus infection.
  • Circulating levels of 104 proteins correlated with DMRs, with many linked to asthma phenotypes.
  • Higher plasma ST2 (IL1RL1) protein levels showed a protective causal effect against asthma.

Conclusions:

  • DNA methylation contributes to asthma development by regulating early-life systemic immune responses.
  • Epigenetic modifications in infancy may serve as biomarkers for future respiratory disease risk.
  • ST2 protein plays a protective role in asthma development, influenced by DNA methylation.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
245
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
242